Integra LifeSciences Holdings Corporation (NasdaqGS: IART)
Health Care · Health Care Equipment & Supplies · US
$16.74
+0.90% today · +12.7% 1Y
Integra LifeSciences Holdings Corporation (NasdaqGS: IART) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.30B and employs 4,427 people.
Over the last twelve months the share price has gained 12.7%, trading between 8.70 and 20.49.
Tweenvest scores Integra LifeSciences Holdings Corporation across four factors: quality 61/100, value 73/100, growth 9/100. Its strongest factor is value.
IART price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.30B
- Revenue (TTM)
- $1.65B
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- 1.21
- 52-week high
- $20.49
- 52-week low
- $8.70
- Avg volume (3M)
- —
- Shares outstanding
- 77.77M
- Employees
- 4,427
- Next earnings
- —
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
- ISIN
- US4579852082
- Founded
- 1989
- Listed since
- Aug 16, 1995
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.85 | +0.18% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $381.93 | +0.82% |
| Stryker CorporationNYSE: SYK | $126.37B | $332.00 | +0.77% |
| Medtronic plcNYSE: MDT | $119.49B | $93.79 | +0.47% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.30 | -0.55% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.60 | +0.46% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.